Good manufacturing practices production of mesenchymal stem/stromal cells

Human Gene Therapy

Volumn 22, Issue 1, 2011, Pages 19-26

  Sensebé, Luc ^a   Bourin, Philippe ^a   Tarte, Karin ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; GENOMIC INSTABILITY; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNOREGULATION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; REPRODUCIBILITY; SAFETY; SENESCENCE; STROMA CELL; VALIDATION PROCESS;

BIOREACTORS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CLINICAL TRIALS AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELLS; QUALITY CONTROL; STROMAL CELLS;

EID: 79951866274     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.197     Document Type: Article

References (54)

1. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Canced-da, R., and Quarto, R. (2000). Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp. Hematol. 28, 707-715. (Pubitemid 30398528)
2. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIn-tosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48. (Pubitemid 34059216)
3. Bartosh, T.J., Ylöstalo, J.H., Mohammadipoor, A., Bazhanov, N., Coble, K., Claypool, K., Lee, R.H., Choi, H., and Prockop, D.J. (2010). Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their inflammatory properties. Proc. Natl. Acad. Sci. U.S.A. 107, 13724-13729.
4. Baxter, M.A., Wynn, R.F., Jowitt, S.N., Wraith, J.E., Fairbairn, L.J., and Bellantuono, I. (2004). Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22, 675-682. (Pubitemid 39172200)
5. Bieback, K., Kern, S., Klüter, H., and Eichler, H. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625-634. (Pubitemid 39014578)
6. Binet, R., Ythier, D., Robles, A.I., Collado, M., Larrieu, D., Fonti, C., Brambilla, E., Brambilla, C., Serrano, M., Harris, C.C., and Pedeux, R. (2009). WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 69, 9183-9191.
7. Campisi, J., and d'Adda di Fagagna, F. (2007). Cellular senescence: When bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740. (Pubitemid 47312822)
8. Caplan, A.I. (1994). The mesengenic process. Clin. Plastic Surg. 21, 429-435. (Pubitemid 24208964)
9. Chase, L.G., Lakshmipathy, U., Solchaga, L.A., Rao, M.S., and Vemuri, M.C. (2010). A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res. Ther. 1, 8.
10. Colter, D.C., Sekiya, I., and Prockop, D.J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. U.S.A. 98, 7841-7845. (Pubitemid 32642648)
11. Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PloS Biol. 12, 2853-2868.
12. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Bü hring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., and Peault, B. (2008). A perivascular origin for mesenchy-mal stem cells in multiple human organs. Cell Stem Cell 3, 301-313.
13. Delorme, B., Ringe, J., Pontikoglou, C., Gaillard, J., Langonné, A., Sensebé, L., Noël, D., Jorgensen, C., Häupl, T., and Char-bord, P. (2009). Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells 27, 1142-1151.
14. 1 integrin subunit-positive. J. Cell. Physiol. 184, 319-325. (Pubitemid 30625494)
15. De Ugarte, D.A., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P.A., Zhu, M., Dragoo, J.L., Ashijan, P., Thomas, B., Benhaim, P., Chen, I., Frazer, J., and Hedrick, M.H. (2003). Comparison of multilineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174, 101-109. (Pubitemid 36819010)
16. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., and Jorgensen, C. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in al-logeneic animals. Blood 102, 3837-3844. (Pubitemid 37409409)
17. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J., and Horwitz, E. (2006). Minimal criteria for defining multi-potent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317. (Pubitemid 44269669)
18. Friedenstein, A.J., Gorskaja, J.F., and Kulagina, N.N. (1976). Fi-broblast precursors in normal and irradiated mouse hemato-poietic organs. Exp. Hematol. 4, 267-274.
19. Garcia, S., Martin, M.C., de la Fuente, R., Cigudosa, J.C., Garcia-Castro, J., and Bernad, A. (2010). Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp. Cell Res. 316, 1648-1650.
20. Godara, P., McFarland, C.D., and Nordon, R.E. (2008). Design of bioreactors for mesenchymal stem cell tissue engineering. J. Chem. Technol. Biotechnol. 83, 408-420. (Pubitemid 351460907)
21. Gronthos, S., Zannettino, A.C.W., Hay, S.J., Shi, S., Graves, S.E., Kortesidis, A., and Simmons, P.J. (2003). Molecular and cellular characterisation of highly purified stromal cells derived from human bone marrow. J. Cell Sci. 116, 1827-1835. (Pubitemid 36582169)
22. Hayflick, L. (1963). The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
23. Houghton, J.M., Li, H., Fan, X., Liu, Y., Liu, J.H., Rao, V., Pou-tahidis, T., Taylor, C.L., Jackson, E.A., Hewes, C., Lyle, S., Cerny, A., Bowen, G., Cerny, J., Moore, N., Kurt-Jones, E.A., and Erdman, S.E. (2010). Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cell Dev. 19, 1153-1166.
24. Kasten, P., Vogel, J., Beyen, I., Weiss, S., Niemeyer, P., Leo, A., and Lü ginbuhl, R. (2008). Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference. J. Biomater. Appl. 23, 169-188.
25. Kern, S., Eichler, H., Stoeve, J., Klüter, H., and Bieback, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301. (Pubitemid 44464698)
26. Kim, J., Kang, J.W., Park, J.H., Choi, Y., Choi, K.S., Park, K.D., Baek, D.H., Seong, S.K., Min, H.-K., and Kim, H.S. (2009). Biological characterization of long-term cultured human mesenchymal stem cells. Arch. Pharm. Res. 32, 117-126.
27. Koç, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynes-worth, S.E., Caplan, A.I., and Lazarus, H.M. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultured-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18, 307-316. (Pubitemid 30056419)
28. Kocaoemer, A., Kern, S., Klüter, H., and Bieback, K. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270-1278. (Pubitemid 46684887)
29. Krishnamurthy, J., Torrice, C., Ramsey, M.R., Kovalev, G.I., Al-Regaiey, K., Su, L., and Sharpless, N.E. (2004). Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299-1307. (Pubitemid 40385301)
30. Mü ller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M.P., Horwitz, E.M., Conte, P., Handgretinger, R., and Dominici, M. (2006). Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437-444. (Pubitemid 44596996)
31. Muraglia, A., Cancedda, R., and Quarto, R. (2000). Clonal mes-enchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 113, 1161-1166. (Pubitemid 30229533)
32. Nauta, A.J., and Fibbe, W.E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499-3506. (Pubitemid 350159613)
33. Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Lakshmi-pathy, U., Choong, C., Yang, Z., Vemuri, M.C., Rao, M.S., and Tanavde, V. (2008). PDGF, TGF-b, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112, 295-307.
34. Park, I.-K., Morrison, S.J., and Clarke, M.F. (2004). Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175-179. (Pubitemid 38544200)
35. Phinney, D.G., and Prockop, D.J. (2007). Concise review: Mes-enchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25, 2896-2902. (Pubitemid 350127874)
36. Prockop, D.J., Brenner, M., Fibbe, W.E., Horwitz, E., LeBlanc, K., Phinney, D.G., Simmons, P.J., Sensebe, L., and Keating, A. (2010). Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12, 576-578.
37. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., and Deluiliers, G.L. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. 30, 783-791. (Pubitemid 34835685)
38. Rojewski, M., Dausend, J., Schmidtke-Schrezenmeier, G., and Schrezenmeier, H. (2010). A standardized protocol for GMP compliant expansion of MSC from BM in an animal component free system. Presented at the XXXIst International Congress of the ISBT in joint cooperation with the 43rd Congress of the DGTI, June 26-July 1, 2010, Berlin, Germany.
39. Rosland, G.V., Svendsen, A., Torsvik, A., Sobala, E., McCor-mack, E., Immervoll, H., Mysliwietz, J., Tonn, J.C., Gold-brunner, R., Lønning, P.E., Bjerkvig, R., and Schichor, C. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 69, 5331-5339.
40. Rubio, D., Garcia-Castro, J., Martin, M.C., de la Fuente, R., Ci-gudosa, J.C., Lloyd, A.C., and Bernad, A. (2005). Spontaneous human adult stem cell transformation. Cancer Res. 65, 3035-3039. (Pubitemid 40524580)
41. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Ferrari, S., Gehron Robey, P., Rimi-nucci, M., and Bianco, P. (2007). Self-renewing osteoprogeni-tors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324-336. (Pubitemid 47592917)
42. Sekiya, I., Larson, B.J., Smith, J.R., Pochampally, R., Cui, J.-G., and Prockop, D.J. (2002). Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530-541. (Pubitemid 35463066)
43. Sensebé, L., and Bourin, P. (2008). Producing MSC according GMP: Process and controls. Biomed. Mater. Eng. 18, 173-177.
44. Sensebé, L., Bourin, P., and Douay, L. (2006). In: Ho, A., Hoffmann, R., and Zanjani, E.D., editors. Good Manufacturing Practices: Clinical-scale production of mesenchymal stem cells in stem cell transplantation. biology, processing, and therapy (Wiley-VCH Verlag, New York).
45. Serakinci, N., Guldberg, P., Burns, J.S., Abdallah, B., Schrodder, H., Jensen, T., and Kassem, M. (2004). Adult human mesen-chymal stem cell as a target for neoplastic transformation. Oncogene 23, 5095-5098. (Pubitemid 38938744)
46. INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25, 2371-2382. (Pubitemid 47480497)
47. Sotiropoulou, P.A., Perez, S.A., Salagianni, M., Baxevanis, C.N., and Papamichail, M. (2006). Cell culture medium composition and translational adult bone-marrow derived stem cell research. Stem Cells 24, 1409-1410. (Pubitemid 44464710)
48. Spees, J.L., Gregory, C.A., Singh, H., Tucker, H.A., Peister, A., Lynch, P.J., Hsu, S.C., Smith, J., and Prockop, D.J. (2004). Internalized antigens must be removed to prepare hypoimmu-nogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9, 747-756. (Pubitemid 38660428)
49. Stolzing, A., Jones, E., McGonagle, D., and Scutt, A. (2008). Age-related changes in human bone marrow-derived mesenchy-mal stem cells: Consequences for cell therapies. Mech. Ageing Dev. 129, 163-173.
50. Takashima, Y., Era, T., Nakao, K., Kondo, S., Kasuga, M., Smith, A.G., and Nishikawa, S.I. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129, 1377-1388. (Pubitemid 46970707)
51. Tarte, K., Gaillard, J., Lataillade, J.J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., Dulong, J., Monnier, D., Gourmelon, P., Gorin, N.C., and Sensebé, L; Société Française de Greffe de Moelle et Thérapie Cellulaire. (2010). Clinical-grade production of human mes-enchymal stromal cells: Occurrence of aneuploidy without transformation. Blood 115, 1549-1553.
52. Torsvik, A., Rosland, G.V., Svendsen, A., Molven, A., Im-mervoll, H., McCormack, E., Lonning, P.E., Primon, M., So-bala, E., Tonn, J.C., Goldbrunner, R., Schichor, C., Mysliwietz, J., Lah, T.T., and Motaln, H. (2010). Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: Putting the research field on track. Cancer Res. 70, 6393-6396.
53. Tyndall, A., Walker, U.A., Cope, A., Dazzi, F., De Bari, C., Fibbe, W., Guiducci, S., Jones, S., Jorgensen, C., Le Blanc, K., Luyten, F., McGonagle, D., Martin, I., Bocelli-Tyndall, C., Pennesi, G., Pistoia, V., Pitzalis, C., Uccelli, A., Wulffraat, N., and Feldmann, M. (2007). Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res. Ther. 9, 301.
54. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., and Ho, A.D. (2008). Replicative senescence of mesenchymal stem cells: A continuous and organized process. PloS One 3, 1-12.